Substance P Inhibitor Promotes Tendon Healing in a Collagenase-Induced Rat Model of Tendinopathy

Abstract

Background:

The substance P–neurokinin 1 receptor pathway has been proposed as a therapeutic target for tendinopathy. However, there is a lack of evidence regarding its practical applications.

Purpose:

To investigate the therapeutic effects of substance P inhibitor (SPI) on inflamed tenocytes in vitro and in a collagenase-induced rat model of tendinopathy in vivo.

Study Design:

Controlled laboratory study.

Methods:

We analyzed the mRNA levels of inflammatory (cyclooxygenase [COX]-2 and interleukin [IL]-6) and tenogenic (Mohawk and scleraxis [SCX]) markers using reverse transcription quantitative polymerase chain reaction to demonstrate the effects of SPI on lipopolysaccharide-treated (inflamed) tenocytes. A collagenase-induced rat model of tendinopathy was created by injecting 20 µL of collagenase into the Achilles tendon. A behavior test using an incapacitance apparatus was performed to detect changes in postural equilibrium. The tendon specimens were obtained, and their gross findings were examined. The tensile strength was measured, and histopathological evaluation was performed (hematoxylin and eosin, alcian blue, and immunohistochemical staining).

Results:

The mRNA levels of COX-2, IL-6, Mohawk, and SCX differed significantly between inflamed tenocytes and those treated with SPI. SPI improved the weight burden in a rat model of tendinopathy in a behavioral test. The specimens of the SPI group showed a normal tendon-like appearance. In the biomechanical test, the tensile strength of the SPI group was significantly greater than that of the tendinopathy group. In the histopathological evaluation, the degree of collagen matrix breakdown was mild in the SPI group. In alcian blue staining, only small focal depositions of proteoglycans and glycosaminoglycans were observed in the SPI group. The SPI group showed decreased expression of IL-6 and neurokinin 1 receptor.

Conclusion:

This study suggests that SPI has therapeutic effects on tendon healing and restoration in a collagenase-induced rat model of tendinopathy.

Clinical Relevance:

SPI is a promising agent for tendinopathy in humans.

Keywords

tendinopathy substance P substance P inhibitor collagenase rat model

Get full access to this article

View all access options for this article.

References

Andersson

Backman

Scott

Lorentzon

Forsgren

Danielson

. Substance P accelerates hypercellularity and angiogenesis in tendon tissue and enhances paratendinitis in response to Achilles tendon overuse in a tendinopathy model. Br J Sports Med. 2011;45(13):1017-1022.

Andersson

Danielson

Alfredson

Forsgren

. Presence of substance P and the neurokinin-1 receptor in tenocytes of the human Achilles tendon. Regul Pept. 2008;150(1-3):81-87.

Andia

Martin

Maffulli

. Advances with platelet rich plasma therapies for tendon regeneration. Expert Opin Biol Ther. 2018;18(4):389-398.

Andres

Murrell

. Treatment of tendinopathy: what works, what does not, and what is on the horizon. Clin Orthop Relat Res. 2008;466(7):1539-1554.

Backman

Andersson

Wennstig

Forsgren

Danielson

. Endogenous substance P production in the Achilles tendon increases with loading in an in vivo model of tendinopathy-peptidergic elevation preceding tendinosis-like tissue changes. J Musculoskelet Neuronal Interact. 2011;11(2):133-140.

Bass

. Tendinopathy: why the difference between tendinitis and tendinosis matters. Int J Ther Massage Bodywork. 2012;5(1):14-17.

Bjur

Alfredson

Forsgren

. The innervation pattern of the human Achilles tendon: studies of the normal and tendinosis tendon with markers for general and sensory innervation. Cell Tissue Res. 2005;320(1):201-206.

Bove

Calcaterra

Brooker

, et al. Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. Osteoarthritis Cartilage. 2003;11(11):821-830.

Dickerson

Undem

Bullock

Winchurch

. Neuropeptide regulation of proinflammatory cytokine responses. J Leukoc Biol. 1998;63(5):602-605.

10.

Fredberg

Stengaard-Pedersen

. Chronic tendinopathy tissue pathology, pain mechanisms, and etiology with a special focus on inflammation. Scand J Med Sci Sports. 2008;18(1):3-15.

11.

Han

Song

, et al. Effects of corticosteroid on the expressions of neuropeptide and cytokine mRNA and on tenocyte viability in lateral epicondylitis. J Inflamm (Lond). 2012;9(1):40.

12.

Han

Choi

Song

, et al. The implication of substance P in the development of tendinopathy: a case control study. Int J Mol Sci. 2017;18(6):1241.

13.

Harirforoosh

Asghar

Jamali

. Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. J Pharm Pharm Sci. 2013;16(5):821-847.

14.

Hart

Archambault

Kydd

Reno

Frank

Herzog

. Gender and neurogenic variables in tendon biology and repetitive motion disorders. Clin Orthop Relat Res. 1998;351:44-56.

15.

Hökfelt

Broberger

Sergeyev

Ubink

Diez

. Neuropeptides—an overview. Neuropharmacology. 2000;39(8):1337-1356.

16.

John

Lodka

Kohl

, et al. Effect of pro-inflammatory and immunoregulatory cytokines on human tenocytes. J Orthop Res. 2010;28(8):1071-1077.

17.

Kamp

Beck

Gebhart

. Combinations of neurokinin receptor antagonists reduce visceral hyperalgesia. J Pharmacol Exp Ther. 2001;299(1):105-113.

18.

Lee

Han

, et al. Substance P, a promising therapeutic target in musculoskeletal disorders. Int J Mol Sci. 2022;23(5):2583.

19.

Koon

Zhao

Zhan

Moyer

Pothoulakis

. Substance P mediates antiapoptotic responses in human colonocytes by Akt activation. Proc Natl Acad Sci U S A. 2007;104(6):2013-2018.

20.

Lin

C-CJ

Chen

W-N

Chen

C-J

Lin

Y-W

Zimmer

Chen

C-C

. An antinociceptive role for substance P in acid-induced chronic muscle pain. Proc Natl Acad Sci U S A. 2012;109(2):e76-e83.

21.

Lipman

Wang

Ting

Soo

Zheng

. Tendinopathy: injury, repair, and current exploration. Drug Des Devel Ther. 2018;12:591-603.

22.

López-García

Lehocký

Humpolíček

Sáha

. HaCaT keratinocytes response on antimicrobial atelocollagen substrates: extent of cytotoxicity, cell viability and proliferation. J Funct Biomater. 2014;5(2):43-57.

23.

Yang

Shen

Lin

. The clinical effect of tendon repair for tendon spontaneous rupture after corticosteroid injection in hands: a retrospective observational study. Medicine (Baltimore). 2016;95(41):e5145.

24.

Lui

Chan

. Expression of sensory neuropeptides in tendon is associated with failed healing and activity-related tendon pain in collagenase-induced tendon injury. Am J Sports Med. 2010;38(4):757-764.

25.

Maffulli

Via

Oliva

. Chronic Achilles tendon disorders: tendinopathy and chronic rupture. Clin Sports Med. 2015;34(4):607-624.

26.

Mahler

Fritschy

. Partial and complete ruptures of the Achilles tendon and local corticosteroid injections. Br J Sports Med. 1992;26(1):7-14.

27.

Marcum

Hanlon

. Recognizing the risks of chronic nonsteroidal anti-inflammatory drug use in older adults. Ann Longterm Care. 2010;18(9):24-27.

28.

Muñoz

Coveñas

. Safety of neurokinin-1 receptor antagonists. Expert Opin Drug Saf. 2013;12(5):673-685.

29.

Muñoz

Rosso

Coveñas

. A new frontier in the treatment of cancer: NK-1 receptor antagonists. Curr Med Chem. 2010;17(6):504-516.

30.

Kim

Han

, et al. Sustained exposure of substance P causes tendinopathy. Int J Mol Sci. 2020;21(22):8633.

31.

Oshita

Tobita

Tajima

Mizuno

. Adipose-derived stem cells improve collagenase-induced tendinopathy in a rat model. Am J Sports Med. 2016;44(8):1983-1989.

32.

Skutek

van Griensven

Zeichen

Brauer

Bosch

. Cyclic mechanical stretching enhances secretion of interleukin 6 in human tendon fibroblasts. Knee Surg Sports Traumatol Arthrosc. 2001;9(5):322-326.

33.

Song

Stål

Forsgren

. Marked effects of tachykinin in myositis both in the experimental side and contralaterally: studies on NK-1 receptor expressions in an animal model. ISRN Inflamm. 2013;2013:907821.

34.

Tsuzaki

Guyton

Garrett

, et al. IL-1 beta induces COX2, MMP-1, -3 and -13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells. J Orthop Res. 2003;21(2):256-264.

35.

Tang

, et al. Substance P attenuates hypoxia/reoxygenation-induced apoptosis via the Akt signalling pathway and the NK1-receptor in H9C2Cells. Heart Lung Circ. 2018;27(12):1498-1506.

36.

Murrell

. The basic science of tendinopathy. Clin Orthop Relat Res. 2008;466(7):1528-1538.

37.

Yamaguchi

Kumakura

Murakami

Someya

Inada

Nagaoka

. Ketamine suppresses the substance P-induced production of IL-6 and IL-8 by human U373MG glioblastoma/astrocytoma cells. Int J Mol Med. 2017;39(3):687-692.